Five trends happening in the laboratory industry - Insights
Managing a successful hospital-based laboratory in today’s economic climate requires leaders to anticipate challenges, navigate obstacles, and develop creative approaches to unusual circumstances. The Mayo Clinic Laboratories outreach team...
Omicron Variant: Dr. Bill Morice - Insights
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...
Pathways Case Studies: May 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for May include the following sub-specialties: Bone and Soft Tissue & Infectious...
December 2022 - Bone and Soft Tissue - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Bone and Soft Tissue Pathology.
New tests launched in November - Insights
In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in July - Insights
In July 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in January - Insights
In January 2019, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Improving diagnosis and treatment of Helicobacter pylori - Insights
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
New Tests Launched in November - Insights
In November 2018, Mayo Clinic Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Accurate Kidney Stone Analysis - Insights
In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic Laboratories’ AI-augmented kidney stone test and discusses the proper procedures for collecting and processing kidney stones to provide accurate, cost-effective analysis of...
Unraveling a diagnostic mystery: Ed Garber - Insights
Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by Mayo Clinic Laboratories gave them the...
Pathways Case Studies: May 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for May include the following sub-specialties: Cytopathology, Gastroenterology...
Christmas Specimen Shipping Guidelines and Schedule - Insights
Due to the Christmas holiday (recognized on Wednesday, Dec. 25), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen stability and prevent delays, follow the guidelines outlined below for...
New tests launched in January - Insights
In January, Mayo Clinic Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.
Thank you for your collaboration in 2023 - Insights
Mayo Clinic Laboratories is grateful for the opportunity to serve you and other healthcare professionals around the globe in providing critical answers and actionable insights.
New Years Holiday Shipment Schedules - Insights
The United States will observe the New Year holiday on Monday, Jan. 1. On this day, Mayo Clinic Laboratories will be open; however, specimen shipments and deliveries to our laboratories will not be made by the carriers. To safeguard...
Grounded in gratitude, embracing treatment with hope - Insights
The fifth episode of “Life of a Specimen” video series highlights Joy Carol’s treatment journey after Mayo Clinic Laboratories antibody testing identified a paraneoplastic autoimmune disorder as the cause of her life-threatening symptoms.
Predictions for 2023: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo...
Behind the scenes in neural antibody testing - Insights
In this month’s “Hot Topic,” John Mills, Ph.D., explains the central role of tissue immunofluorescence in the identification of neural antibodies and discusses the benefits of an integrated laboratory approach to the development and...
Autoimmune Axonal Evaluation - Insights
Div Dubey, M.B.B.S., explains Mayo Clinic Laboratories' phenotypic testing approach for autoimmune axonal neuropathy. The comprehensive, serologic panel detects for antibodies with clinical relevance to the disease to provide clarity on...
Pathologists' Important Roles in Community Medicine - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with Vipul Trivedi, M.D., chair of Pathology at Mayo Clinic Health System and chair...
Autoimmune Myelopathy Evaluation [Test in Focus] - Insights
Patients with autoimmune myelopathy present with subacute onset and rapid progression of spinal cord symptoms (weakness, gait difficulties, loss of sensation, neuropathic pain, and bowel and bladder dysfunction). Autoimmune myelopathy...
Candida Auris: Dr. Nancy Wengenack - Insights
Nancy Wengenack, Ph.D., director of the Mycology and Microbacteriology Laboratories in Mayo Clinic’s Department of Laboratory Medicine and Pathology, joins the "Answers From the Lab" podcast this week. In this episode, Dr. Wengenack and...
A "sandbox" for innovation: The Advanced Diagnostics Laboratory - Insights
Mayo Clinic’s Advanced Diagnostics Laboratory (ADL) is a visionary space designed to foster innovation. The ADL has a direct impact on patient lives, bringing promising tests and services to patients at Mayo and around the world.
Pathways Case Studies: December 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for December include the following sub-specialties: Cardiovascular Pathology and...
Mayo Clinic Laboratory and pathology research roundup: December 13 - Insights
This week's research roundup features: In vitro activity of a hypochlorous acid-generating electrochemical bandage against yeast biofilms
Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros - Insights
One summer morning, James Kypuros awoke to find his toes stiffened like claws. Then he started having falls, which culminated in losing his ability to walk or even sit up without help. Diagnosed with stiff-person syndrome, James wouldn’t...
P.A.C.E./Florida Implementation of new analyzers and replacement of automation equipment in the Central Clinical Laboratory at Mayo Clinic in Rochester, Minnesota, prompted the laboratory to reassess blood collection volumes for commonly...
Talking omicron with Matthew Binnicker, Ph.D. - Insights
With the omicron variant grabbing headlines around the world, media outlets have turned to experts like Dr. Binnicker to help clarify the effect this new variant could have and what it might mean for the COVID-19 pandemic.
Diagnostic Testing Algorithms for Celiac Disease - Insights
In this month's "Hot Topic," Melissa Snyder, Ph.D., co-director of the antibody immunology laboratory at Mayo Clinic, discusses celiac disease and the role of diagnostic testing algorithms.
CPT codes and LOINC update: November 2024 - Insights
This page lists updates posted to Mayo Clinic Labs during the month of November.
The 10 Types of Attendees You May Find at a Conference - Insights
Heidi Zunker, Education Program Manager, and Melissa Peterson, Education Specialist, at Mayo Medical Laboratories, discuss the 10 types of attendees you may find at a conference.
Respiratory illness updates and health care economics - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology...
CPT codes and LOINC update: November 2022 - Insights
This list includes updates posted to mayocliniclabs.com during the month of November.
CPT codes and LOINC update: November 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of November.
Our staff, our stories: Rondell Graham - Insights
Dr. Graham recalls how his upbringing influenced his outlook on life and discusses the power of investing in relationships.
Liquid Biopsies: Detecting and Treating Cancer Sooner - Insights
Researchers and physicians at Mayo Clinic are collaborating and developing blood tests that detect tumor related material in the blood and may someday be used in place of a biopsy or imaging test to detect and monitor cancer growth.
Debunking mask myths: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this...
New communication process for CPT Code changes - Insights
Mayo Clinic Laboratories (MCL) is pleased to announce an essential update to our CPT code communication process and website layout. This change is designed to bring timely notifications for accurate billing information.
New Year's Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered for the New Year's holiday. To ensure specimen viability and minimize delays, the following adjustments and guidelines have been implemented and will be...
Christmas and New Year's specimen shipment alert - Insights
Due to the Christmas and New Year's holiday's (recognized on Saturday, December 25th, and Saturday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and...
Global Surgery Hackathon: Lessons in Healthcare Systems - Insights
In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., speaks with medical students on the importance of understanding healthcare systems, their experiences from a global surgery hackathon, and how maintaining curiosity and...
Ensuring quality in the lab: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology...
Our Staff, Our Stories: Darin Kittleson - Insights
From friendly neighbor, to a hero. Darin Kittleson was in the middle of his ordinary day snow plowing his driveway when he decided to plow his neighbor’s driveway, as well. That was when he heard the cry for help. Darin rushed inside as 911...
Gastrointestinal Stromal Tumor Panel [Test in Focus] - Insights
Rondell P. Graham, M.B.B.S., gives an overview of this test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon previous testing approaches, what clinical action can...
Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated...
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights
In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...
Cardiovascular Events in Patients With or Without Coronary Artery Disease
A new type of blood test may help physicians identify which patients with and without evidence of coronary blockages are at risk for heart attacks and strokes. Even individuals with normal levels of low-density lipoprotein (LDL), known as...
MCL Rare Coagulation Disorder Patient Information MC1235264
MCL Rare Coagulation Disorder Patient Information Complete print Reset Form Rare Coagulation Disorder Patient Information Instructions Genetic testing rare hereditary disorders blood coagulation
After a long wait, the U.S. Food and Drug Administration has finally approved the Elecsys Troponin T Gen 5 STAT blood test. Recently, the Beckman hscTnI assay was also approved. These high-sensitivity troponin assays will benefit emergency...